148 related articles for article (PubMed ID: 3443256)
21. Plasma pancreastatin responses after intrajejunal infusion of liquid meal in patients with chronic pancreatitis.
Funakoshi A; Tateishi K; Shinozaki H; Miyasaka K; Ito T; Wakasugi H
Dig Dis Sci; 1990 Jun; 35(6):721-5. PubMed ID: 2188821
[TBL] [Abstract][Full Text] [Related]
22. Action of pancreatic polypeptide on exocrine pancreas and on release of cholecystokinin and secretin.
Lonovics J; Guzman S; Devitt PG; Hejtmancik KE; Suddith RL; Rayford PL; Thompson JC
Endocrinology; 1981 May; 108(5):1925-30. PubMed ID: 7215307
[TBL] [Abstract][Full Text] [Related]
23. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers.
Niederau C; Schwarzendrube J; Lüthen R; Niederau M; Strohmeyer G; Rovati L
Pancreas; 1992; 7(1):1-10. PubMed ID: 1557335
[TBL] [Abstract][Full Text] [Related]
24. Cholecystokinin acts as an essential factor in the exacerbation of pancreatic bile duct ligation-induced rat pancreatitis model under non-fasting condition.
Yoshinaga K; Washizuka M; Segawa Y
Jpn J Pharmacol; 2000 Sep; 84(1):44-50. PubMed ID: 11043452
[TBL] [Abstract][Full Text] [Related]
25. Effects of ethanol on meal-stimulated secretion of pancreatic polypeptide and cholecystokinin: comparison of healthy volunteers, heavy drinkers, and patients with chronic pancreatitis.
Hirano H; Shimosegawa T; Meguro T; Shiga N; Koizumi M; Toyota T
J Gastroenterol; 1996 Feb; 31(1):86-93. PubMed ID: 8808434
[TBL] [Abstract][Full Text] [Related]
26. Diurnal profile of plasma motilin concentrations during fasting and feeding in man.
Funakoshi A; Ho LL; Jen KL; Knopf R; Vinik AI
Gastroenterol Jpn; 1985 Oct; 20(5):446-56. PubMed ID: 3908210
[TBL] [Abstract][Full Text] [Related]
27. Necessity of hyperglycemia for effects of endogenous cholecystokinin on insulin and pancreatic exocrine secretion in conscious rats.
Shikado F; Miyasaka K; Funakoshi A; Kitani K
Jpn J Physiol; 1990; 40(3):383-91. PubMed ID: 2273636
[TBL] [Abstract][Full Text] [Related]
28. Plasma concentrations of cholecystokinin and neurotensin in patients with cystic fibrosis.
Herzig KH; Domagk J; Nustede R; Stern M; Bewig B; Cichy WK; Fölsch UR
Scand J Gastroenterol; 1997 Apr; 32(4):315-9. PubMed ID: 9140152
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of increased exocrine pancreatic secretion in pancreatic juice-diverted rats.
Shiratori K; Chen YF; Chey WY; Lee KY; Chang TM
Gastroenterology; 1986 Nov; 91(5):1171-8. PubMed ID: 3758609
[TBL] [Abstract][Full Text] [Related]
30. Relationship between postprandial release of CCK and PP in health and in chronic pancreatitis.
Glasbrenner B; Dominguez-Muñoz JE; Nelson DK; Riepl RL; Büchler M; Malfertheiner P
Regul Pept; 1994 Feb; 50(1):45-52. PubMed ID: 8159806
[TBL] [Abstract][Full Text] [Related]
31. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.
Chowdhury P; Rayford PL
Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849
[TBL] [Abstract][Full Text] [Related]
32. Effect of L-364,718 on GRP-stimulated pancreatic and gastric secretions and GI peptides in conscious dogs.
Hosotani R; Chowdhury P; Huang YS; McKay D; Yajima H; Rayford PL
Pancreas; 1989; 4(5):550-5. PubMed ID: 2813326
[TBL] [Abstract][Full Text] [Related]
33. Meal-related changes in plasma CCK bioactivity in patients with chronic pancreatitis.
Nakamura T; Tando Y; Yamada N; Imamura K; Ishii M; Terada A; Takebe K; Kaji A; Watanabe T; Suda T; Koide M; Otsuki M
Acta Gastroenterol Belg; 1998; 61(4):400-6. PubMed ID: 9923089
[TBL] [Abstract][Full Text] [Related]
34. [Addition of albumin to solutions of cholecystokinin (CCK)--effect on pancreatic secretion, plasma CCK level and release of pancreatic polypeptide (PP)].
Fried M; Gyr K; Beglinger C; Schlegel W; Grötzinger U; Stalder GA; Varga L
Z Gastroenterol; 1983 Mar; 21(3):129-33. PubMed ID: 6868720
[TBL] [Abstract][Full Text] [Related]
35. Role of endogenous cholecystokinin on vagally stimulated pancreatic secretion in dogs.
Kim CK; Lee KY; Wang T; Sun G; Chang TM; Chey WY
Am J Physiol; 1989 Dec; 257(6 Pt 1):G944-9. PubMed ID: 2481981
[TBL] [Abstract][Full Text] [Related]
36. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S
Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622
[TBL] [Abstract][Full Text] [Related]
37. Effect of acute hyperglycaemia on basal and fat-induced exocrine pancreatic secretion in humans.
Lam WF; Muller ES; Souverijn JH; Lamers CB; Masclee AA
Clin Sci (Lond); 1997 Dec; 93(6):573-80. PubMed ID: 9497795
[TBL] [Abstract][Full Text] [Related]
38. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
[TBL] [Abstract][Full Text] [Related]
39. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic polypeptide secretion in patients with chronic pancreatitis and after pancreatic surgery.
Eddes EH; Verkijk M; Gielkens HA; Biemond I; Bemelman W; Lamers CB; Masclee AA
Int J Pancreatol; 2001; 29(3):173-80. PubMed ID: 12067221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
